Premier, Inc.

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: US74051N1028
USD
28.26
0.09 (0.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

620.77 k

Shareholding (Mar 2025)

FII

16.81%

Held by 152 FIIs

DII

28.34%

Held by 68 DIIs

Promoter

0.09%

How big is Premier, Inc.?

22-Jun-2025

As of Jun 24, Premier, Inc. has a market capitalization of 1,975.17 million, with net sales of 1,100.06 million and net profit of 115.31 million over the last four quarters. Shareholder's funds are 1,962.23 million, and total assets amount to 3,428.59 million.

As of Jun 18, Premier, Inc. has a market capitalization of 1,975.17 million, categorizing it as a Small Cap company.<BR><BR>As of Jun 24, the sum of Net Sales for the latest four quarters is 1,100.06 million, while the sum of Net Profit for the same period is 115.31 million.<BR><BR>As of Jun 24, the reporting period shows Shareholder's Funds at 1,962.23 million and Total Assets at 3,428.59 million.

Read More

What does Premier, Inc. do?

22-Jun-2025

Premier, Inc. is a healthcare improvement company focused on the hospital industry, with recent net sales of $261 million and a net profit of $28 million. It has a market cap of approximately $1.98 billion and key metrics include a P/E ratio of 14.00 and a dividend yield of 380.78%.

Overview:<BR>Premier, Inc. is a healthcare improvement company operating in the hospital industry, categorized as a small-cap entity.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 261 Million (Quarterly Results - Mar 2025)<BR>Most recent Net Profit: 28 Million (Quarterly Results - Mar 2025)<BR>Market-cap: USD 1,975.17 Million (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 14.00<BR>Dividend Yield: 380.78%<BR>Debt Equity: 0.57<BR>Return on Equity: 9.26%<BR>Price to Book: 1.30<BR><BR>Contact Details:<BR>Address: 13034 Ballantyne Corporate Pl, CHARLOTTE NC: 28277-1498<BR>Tel: ['1 704 3570022', '1 704 8163888']<BR>Fax: 1 302 6555049<BR>Website: https://www.premierinc.com/

Read More

Should I buy, sell or hold Premier, Inc.?

22-Jun-2025

Who are in the management team of Premier, Inc.?

22-Jun-2025

As of March 2022, the management team of Premier, Inc. includes Chairman Terry Shaw, CEO Susan DeVore, Lead Independent Director William Mayer, and Directors Barclay Berdan, Peter Fine, Marc Miller, and Marvin O'Quinn. They oversee the company's operations and strategic direction.

As of March 2022, the management team of Premier, Inc. includes the following individuals:<BR><BR>- Mr. Terry Shaw, Chairman of the Board<BR>- Ms. Susan DeVore, Chief Executive Officer and Director<BR>- Mr. William Mayer, Lead Independent Director<BR>- Mr. Barclay Berdan, Director<BR>- Mr. Peter Fine, Director<BR>- Mr. Marc Miller, Director<BR>- Mr. Marvin O'Quinn, Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Read More

Is Premier, Inc. technically bullish or bearish?

20-Sep-2025

As of September 8, 2025, Premier, Inc. shows a bullish technical trend with positive indicators like the weekly MACD and daily moving averages, despite mixed long-term performance compared to the S&P 500.

As of 8 September 2025, the technical trend for Premier, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. The Bollinger Bands show a bullish signal on the monthly timeframe, while the KST is bullish in both weekly and monthly views. However, the RSI does not provide any signals in either timeframe. <BR><BR>In terms of performance, Premier, Inc. has outperformed the S&P 500 over the past month (8.15% vs. 2.33%) and year-to-date (24.62% vs. 12.22%), but it has significantly underperformed over the longer three and five-year periods. Overall, the current technical stance is bullish, supported by multiple indicators, despite mixed longer-term performance.

Read More

Is Premier, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Premier, Inc. is considered overvalued with a valuation grade of very expensive, reflected by its P/E ratio of 14 and poor long-term performance, despite a strong year-to-date return of 32.08%.

As of 17 October 2025, the valuation grade for Premier, Inc. moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears overvalued based on its current metrics, with a P/E ratio of 14, an EV to EBITDA ratio of 13.73, and a Price to Book Value of 1.34. In comparison, Universal Health Services, Inc. has a P/E of 9.20 and an EV to EBITDA of 6.78, while National HealthCare Corp. shows a fair valuation with a P/E of 18.51.<BR><BR>Despite a strong year-to-date return of 32.08% compared to the S&P 500's 13.30%, the long-term performance reveals a concerning trend, with a 3-year return of -17.89% versus the S&P 500's 81.19%. This discrepancy further supports the conclusion that Premier, Inc. is currently overvalued.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of -4.87% and Operating profit at -17.75% over the last 5 years

 
2

With a fall in Net Sales of -4.42%, the company declared Very Negative results in Jun 25

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

USD 2,412 Million (Small Cap)

stock-summary
P/E

14.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

208.92%

stock-summary
Debt Equity

0.13

stock-summary
Return on Equity

13.96%

stock-summary
Price to Book

1.58

Revenue and Profits:
Net Sales:
263 Million
(Quarterly Results - Jun 2025)
Net Profit:
18 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.41%
0%
12.41%
6 Months
22.55%
0%
22.55%
1 Year
23.73%
0%
23.73%
2 Years
35.09%
0%
35.09%
3 Years
-14.62%
0%
-14.62%
4 Years
-28.18%
0%
-28.18%
5 Years
-19.76%
0%
-19.76%

Premier, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-4.87%
EBIT Growth (5y)
-17.75%
EBIT to Interest (avg)
22.53
Debt to EBITDA (avg)
1.94
Net Debt to Equity (avg)
0.57
Sales to Capital Employed (avg)
0.53
Tax Ratio
27.50%
Dividend Payout Ratio
80.39%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
8.15%
ROE (avg)
9.49%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.34
EV to EBIT
31.16
EV to EBITDA
13.73
EV to Capital Employed
1.21
EV to Sales
2.64
PEG Ratio
0.19
Dividend Yield
369.41%
ROCE (Latest)
3.90%
ROE (Latest)
9.26%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 101 Schemes (54.66%)

Foreign Institutions

Held by 152 Foreign Institutions (16.81%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.57% vs 8.78% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -34.78% vs 160.26% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "262.90",
          "val2": "261.40",
          "chgp": "0.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "63.80",
          "val2": "70.60",
          "chgp": "-9.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6.30",
          "val2": "5.40",
          "chgp": "16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-9.40",
          "val2": "-7.60",
          "chgp": "-23.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "18.00",
          "val2": "27.60",
          "chgp": "-34.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "130.50%",
          "val2": "158.30%",
          "chgp": "-2.78%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2025 is -24.79% vs 0.77% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2025 is -31.87% vs -38.99% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,012.60",
          "val2": "1,346.40",
          "chgp": "-24.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "265.50",
          "val2": "286.10",
          "chgp": "-7.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "17.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-146.80",
          "val2": "-29.10",
          "chgp": "-404.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "72.70",
          "val2": "106.70",
          "chgp": "-31.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "146.00%",
          "val2": "116.70%",
          "chgp": "2.93%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
262.90
261.40
0.57%
Operating Profit (PBDIT) excl Other Income
63.80
70.60
-9.63%
Interest
6.30
5.40
16.67%
Exceptional Items
-9.40
-7.60
-23.68%
Consolidate Net Profit
18.00
27.60
-34.78%
Operating Profit Margin (Excl OI)
130.50%
158.30%
-2.78%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.57% vs 8.78% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -34.78% vs 160.26% in Mar 2025

Annual Results Snapshot (Consolidated) - Jun'25stock-summary
Jun'25
Jun'24
Change(%)
Net Sales
1,012.60
1,346.40
-24.79%
Operating Profit (PBDIT) excl Other Income
265.50
286.10
-7.20%
Interest
17.20
0.00
Exceptional Items
-146.80
-29.10
-404.47%
Consolidate Net Profit
72.70
106.70
-31.87%
Operating Profit Margin (Excl OI)
146.00%
116.70%
2.93%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Jun 2025 is -24.79% vs 0.77% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jun 2025 is -31.87% vs -38.99% in Jun 2024

stock-summaryCompany CV
About Premier, Inc. stock-summary
stock-summary
Premier, Inc.
Hospital
Premier, Inc. is a healthcare improvement company. The Company is uniting an alliance of approximately 4,000 United States hospitals and health systems and approximately 175,000 other providers and organizations to transform healthcare. The Company operates through two reportable business segments: Supply Chain Services and Performance Services. Its Supply Chain Services segment operates healthcare group purchasing organizations (GPO) and direct sourcing activities. The Company’s performance Service segment provides integrated data and analytics, software as a service (SaaS) informatic products, consulting services, performance improvement collaborative, government services and insurance management services. The Company plays a role in the healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide.
Company Coordinates stock-summary
Company Details
13034 Ballantyne Corporate Pl , CHARLOTTE NC : 28277-1498
stock-summary
Tel: 1 704 35700221 704 8163888
stock-summary
Registrar Details